SARA JACKSON: Open Payments
NPI 1720716475 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$465 in 25 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $184 · 2025 $465
Food & beverage: $465
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 12 | $185 |
| Axsome Therapeutics, Inc. | 2 | $56 |
| Alkermes, Inc. | 2 | $48 |
| Vanda Pharmaceuticals Inc. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $33 |
| ABBVIE INC. | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
Products named: REXULTI, Auvelity, LYBALVI, FANAPT, CAPLYTA, COBENFY, VRAYLAR, INGREZZA.
Industry payments across PA — which companies pay providers there.
